The current valuation score of Eton Pharmaceuticals Inc is 7.37, ranking 106 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -835.34, which is -112.39% below the recent high of 103.51 and -5.62% above the recent low of -882.31.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.